secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apellis Pharmaceuticals, Inc. (APLS)
CIK:        0001492422
Form:       8-K
Filed at:   2021-08-19T23:59:59+00:00
Accession:  0001193125-21-251478
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Apellis principal accounting officer Nicole Perry to depart Aug 30, 2021
------------------------------------------------------------------------

- Nicole Perry will transition from principal accounting officer role effective August 30, 2021.
- No successor or interim replacement has been announced.
- Filing does not specify whether Perry will remain with the company in another capacity.
- Reason for the departure is not disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492422/000119312521251478/0001193125-21-251478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492422/000119312521251478/d198481d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-251478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer